Athenahealth ATHN reported December results of $0.28 on $69.4 million versus the consensus of $0.20 on $67.6 million. Strong collections and higher Clinicals/Communicator penetration overcame a 3-4% reduction in average physician volumes. Higher levels of automation combined with some expense reversals to drive significant margin expansion.
Morgan Keegan believes that ATHN has significant advantages due to the flexibility of its web-based technology and the cash flow improvement that physicians enjoy after adopting its platform. Although the margin expansion this quarter partially benefitted from some one-time items, it also demonstrated that ATHN has the ability to be dramatically more profitable.
Morgan Keegan has a $49 PT and Outperform rating on ATHN
ATHN is trading lower at $46.09
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in